507 days ago
I start with a few words on Jubilee Metals (JLP) and Bluebird Merchant Ventures (BMV). Then some Trustpilot detective work on AQRU (AQRU) which, I predict, will go bust in 2023. I move on to Xtract Resources (XTR), Shearwater (SWG), Alliance Pharma (APH) and then to the impending demise of Applied Graphene Materials (AGM). Gotcha! I also cover Argo Blockchain (ARB) which I still have down as a 2022 bust, maybe as soon as this week
2168 days ago
This is, of course, a big fave of Nigel Wray and he has done exceptionally well from Alliance Pharma (APH). It has also been a good share tip (twice) from myself and young Steve on the Nifty Fifty. The main man is John Dawson and he can explain the story going forward.
2326 days ago
Alliance Pharma (APH) has announced a $7.5 million acquisition from medical technology company Smith & Nephew, with CEO John Dawson emphasising “the acquisition will be immediately earnings enhancing, accretive to our underlying return on invested capital, and it fits well in our existing bedrock business operations”…
2461 days ago
Alliance Pharma (APH) has updated on trading for the first half of 2017, ahead of a results announcement expected on 13th September…
2513 days ago
Alliance Pharma (APH) has made an AGM update announcement, including that trading “is good and in line with the board's expectations” and that “cash flow in the business remains strong”. This is a healthy reaffirmation of our BUY tip of last month which is now well in the money.
2553 days ago
Specialty pharmaceutical company, Alliance Pharma (APH) is a previous successful share tip for us - recommended at 31p, with gains banked at 43p in 2015. However, there has since been positive development which looks inadequately reflected in a current sub 50p offer price and, noting also the continued presence of famed investors Nigel Wray and Slater Investments as major shareholders…
2889 days ago
Alliance Pharma (APH) has, relatively, recently completed a transformational acquisition. I know that Nigel Wray remains a big fan as does Mark Slater. Sensible value investors should thus find the presentation by John Dawson of interest
3064 days ago
Oh no Paul Scott is giving me health advice again. If he promises never ever to waterboard me again with online retail gross margins I might just quit smoking. Away from that I look at car crash Slater & Gordon (SGH) following up from the earlier detailed piece HERE. In a similar vein I look at NAHL (NAH). Then it is onto EKF Diagnostics (EKF), Moneyswap (SWAP), Oilex (OEX), Forte Energy (FTE), Alliance Pharma (APH), Iofina (IOF) and the Fitbug (FITB) dog. There is no mention of Jabba The Hutt today, David Lenigas must wait for Gold & Bears on Saturday for his next drubbing. And boy will it be a drubbing.
